✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Bandaram Pharma Packtech Ltd.

BANDARAM

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹71 Cr.
P/E
354.07

Bandaram Pharma Packtech Ltd.

  • Bandaram Pharma Pack
  • Makers Laboratories
  • Shelter Pharma

FAQs on Bandaram Pharma Packtech Ltd. Shareprice

Bandaram Pharma Pack has given better returns compared to its competitors.
Bandaram Pharma Pack has grown at ~-21.4% over the last 1yrs while peers have grown at a median rate of -28.0%

Yes, Bandaram Pharma Pack is expensive.
Latest PE of Bandaram Pharma Pack is 354, while 3 year average PE is 63.81.
Also latest EV/EBITDA of Bandaram Pharma Pack is 40.49 while 3yr average is 25.34.

View FAQ's On Business

Growth Table

  • Bandaram Pharma Packtech Ltd.
  • Makers Laboratories
  • Shelter Pharma

Balance Sheet

  • Bandaram Pharma Packtech Ltd.
  • Makers Laboratories
  • Shelter Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Bandaram Pharma Packtech Ltd.
  • Makers Laboratories
  • Shelter Pharma

Cash Flow

  • Bandaram Pharma Packtech Ltd.
  • Makers Laboratories
  • Shelter Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Bandaram Pharma Packtech Ltd.
  • Makers Laboratories
  • Shelter Pharma

Quarterly Results

  • Bandaram Pharma Packtech Ltd.
  • Makers Laboratories
  • Shelter Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Bandaram Pharma Packtech Ltd. Financials

Balance sheet of Bandaram Pharma Pack is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Bandaram Pharma Pack is increasing.
Latest net debt of Bandaram Pharma Pack is ₹21.52 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹17.02 Crs.

Yes, profit is increasing.
The profit of Bandaram Pharma Pack is ₹0.55 Crs for Mar 2025, ₹0.52 Crs for Mar 2024 and ₹0.26 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Bandaram Pharma Pack latest dividend payout ratio is 21.95% and 3yr average dividend payout ratio is 18.88%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech